Par Pharmaceutical: Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS
/CNW/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800...
Read full article »
CEO
Par Pharmaceutical develops, manufactures and markets generic and branded specialty pharmaceutical products in the United States.
Read more